in a secondary prevention trial conducted by the national heart , lung , and blood institute , the effect of lipid lowering by drug intervention on the progression of existing coronary artery disease ( cad ) was evaluated in type ii hyperlipidemic patients .
C0018787
heart
C0018799
the